 SOUTH SAN FRANCISCO, Calif., Feb. 24, 2022 GLOBE NEWSWIRE -- Pliant Therapeutics, Inc. Nasdaq: PLRX, a clinical stage biotechnology company focused on discovering and developing novel therapeutics for the treatment of fibrosis, today announced that Bernard Coulie, M.D., Ph.D., Pliants President and Chief Executive Officer, will participate in the following conferences in March. 